טוען...

Six Months of Parathyroid Hormone (1–84) Administered Concurrently Versus Sequentially with Monthly Ibandronate Over Two Years: The PTH and Ibandronate Combination Study (PICS) Randomized Trial

CONTEXT: PTH therapy improves bone mineral density (BMD) and decreases fractures in postmenopausal osteoporosis, but cost and the burden of daily injections limit its use. OBJECTIVE: We evaluated two novel approaches to the use of 6 months of PTH therapy over 2 yr. DESIGN, SETTING, PARTICIPANTS, AND...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Schafer, Anne L., Sellmeyer, Deborah E., Palermo, Lisa, Hietpas, Jean, Eastell, Richard, Shoback, Dolores M., Black, Dennis M.
פורמט: Artigo
שפה:Inglês
יצא לאור: Endocrine Society 2012
נושאים:
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC3674294/
https://ncbi.nlm.nih.gov/pubmed/22791766
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2012-1844
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!